PHASE III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin in Prevention and Reduction of Oxaliplatin-induced Painful Neuropathy.
Phase of Trial: Phase III
Latest Information Update: 12 May 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms PreOx
- 30 Sep 2016 Primary endpoint has not been met.
- 30 Sep 2016 Results (n=162) presented at the 16th World Congress on Pain
- 14 Oct 2011 New trial record